Cue Biopharma (CUE) vs Minerva Neurosciences (NERV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Minerva Neurosciences (NERV) has outperformed Cue Biopharma (CUE) over the past year, gaining 50.0% versus a loss of 0.2%. Over five years, NERV leads with a -69.7% price change compared with -94.0% for CUE. Cue Biopharma is the larger company by market cap ($163.5 million vs $156.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CUE | NERV |
|---|---|---|
| Share price | $22.51 | $3.27 |
| Market cap | $163.52M | $156.13M |
| 1-day change | -2.72% | -4.66% |
| YTD return | +146.01% | -18.66% |
| 1-year return | -0.22% | +50.00% |
| 5-year return | -94.04% | -69.72% |
| EPS (TTM) | $-29.59 | $-34.49 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $45.50 | $12.46 |
| 52-week low | $4.98 | $2.24 |
| Distance from 52-week high | -50.53% | -73.76% |
| Average volume | 269.82K | 185.68K |
| Shares outstanding | 7.26M | 47.75M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NERV has outperformed CUE by 50.2 percentage points over the past year.
CUE vs NERV FAQ
Which is bigger, Cue Biopharma or Minerva Neurosciences?
Cue Biopharma (CUE) is larger, with a market capitalization of $163.52M compared with $156.13M for Minerva Neurosciences (NERV).
Which stock has performed better over the past year, CUE or NERV?
NERV returned +50.00% over the past 12 months, compared with -0.22% for CUE (price return, excluding dividends). Past performance does not predict future results.
Are Cue Biopharma and Minerva Neurosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.